ACUTE LEUKEMIAS XV
Biology and Treatment Strategies

International Symposium

Corporate Support

Further options of supporting ACUTE LEUKEMIAS XV are listed below and in our detailed list of Support Opportunities.

List of Support Opportunities (PDF-Download 157 KB)

 

For more information contact the Organizing Office ACUTE LEUKEMIAS XV:
Beate Buske-Kosel, M.A. (info@acute-leukemias.de)

 

The support of ACUTE LEUKEMIAS XV by the following companies is gratefully acknowledged:

 

Gold Circle Corporate Members:

 

Amgen GmbH
SAT III: Monday, Feb 23, 2014
€ 20.000

 

 

Celgene GmbH
SAT IV: Tuesday, Feb 24, 2014
€ 20.000

Gilead Sciences GmbH
MTP II: Monday, Feb 23, 2014 and AGIHO Grant
€ 18.000

 

Janssen-Cilag GmbH
SAT II: Sunday, Feb 22, 2014
€ 18.000

Pfizer Pharma GmbH
SAT I: Sunday, Feb 22, 2014
€ 18.000

TEVA GmbH
SAT V: Tuesday, Feb 24, 2014
€ 20.000

 

 

Silver Circle Corporate Member:

 

Neovii Biotech GmbH
MTP I: Monday, Feb 23, 2014
€ 10.000

 

Roche Pharma AG (tbc)
MTP II: Monday, Feb 23, 2014 

€ 10.000